![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.leu.2404918/MediaObjects/41375_2008_Article_BF2404918_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.leu.2404918/MediaObjects/41375_2008_Article_BF2404918_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.leu.2404918/MediaObjects/41375_2008_Article_BF2404918_Fig3_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fsj.leu.2404918/MediaObjects/41375_2008_Article_BF2404918_Fig4_HTML.jpg)
References
Yang L, Han Y, Saurez Saiz F, Minden MD . A tumor suppressor and oncogene: the WT1 story. Leukemia 2007; 21: 868–876.
Dehbi M, Hiscott J, Pelletier J . Activation of the WT1 Wilms' tumor suppressor gene by NF-kappaB. Oncogene 1998; 16: 2033–2039.
Mitsiades N, Mitsiades CS, Richardson PG, Poulaki V, Tai YT, Chauhan D et al. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications. Blood 2003; 101: 2377–2380.
Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB . Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J Biol Chem 2006; 281: 5612–5622.
Fazzi R, Pacini S, Testi R, Azzarà A, Galimberti S, Testi C et al. Carboxy-terminal fragment of osteogeneic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis. Br J Haematol 2003; 121: 76–85.
Khan R, Aggerholm A, Hokland P, Hassan M, Hellström-Lindberg E . A pharmacodynamic study of 5-azacytidine in the P39 cell line. Exp Hematol 2006; 34: 35–43.
Galimberti S, Guerrini F, Carulli G, Fazzi R, Palumbo GA, Morabito F et al. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis. Eur J Haematol 2004; 72: 45–51.
Sutheesophon K, Kobayashi Y, Takatoku MA, Ozawa K, Kano Y, Ishii H et al. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib. Acta Haematol 2006; 115: 78–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Galimberti, S., Canestraro, M., Khan, R. et al. Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines. Leukemia 22, 628–631 (2008). https://doi.org/10.1038/sj.leu.2404918
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404918
- Springer Nature Limited